Zhejiang Hisun Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is PRAVASTATIN SODIUM USP (PROCESS II), with a corresponding US DMF Number 27615.
Remarkably, this DMF maintains an Active status since its submission on October 21, 2013, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 07, 2014, and payment made on May 06, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II